基本信息
views: 33

Bio
Medicinal Chemistry, Ligand targeted Drug Conjugates, Fluorescence and Radio Imaging agents, Immunotherapy
Research Interests
Papers共 46 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Dhanashree Murugan, Harashkumar Vasanthakumari Thirumalaiswamy, Vasanth Murugesan, Janarthanan Venkatesan, Unnikrishnan Balachandran, Kalaiarasu Lakshminarayanan, Drishty Satpati, Stefan Nikolić,Loganathan Rangasamy
Pharmacology & therapeutics (2025): 108863-108863
Akshay Kodiyawala, Arindam Mondal,Dhanashree Murugan,Loganathan Rangasamy,Suban K. Sahoo,Subrata Dutta
JOURNAL OF MOLECULAR STRUCTURE (2025)
Ilemobayo Victor Fasogbon,Erick Nyakundi Ondari,Deusdedit Tusubira,Loganathan Rangasamy, Janarthanan Venkatesan, Angela Mumbua Musyoka,Patrick Maduabuchi Aja
RSC ADVANCESno. 43 (2024): 31704-31722
Janarthanan Venkatesan,Dhanashree Murugan, Kalaiarasu Lakshminarayanan, Alexis R. Smith, Harashkumar Vasanthakumari Thirumalaiswamy, Hariprasath Kandhasamy, Boutheina Zender,Guangrong Zheng,Loganathan Rangasamy
Pharmacology & therapeutics (2024): 108725-108725
BIOLOGY METHODS & PROTOCOLSno. 1 (2024): bpae034-bpae034
Anjitha Theres Benny,Masthan Thamim,Prakhar Srivastava, Sindoora Suresh,Krishnan Thirumoorthy,Loganathan Rangasamy, S. Karthikeyan,Nalini Easwaran,Ethiraj Kannatt Radhakrishnan
Kalaiarasu Lakshminarayanan,Dhanashree Murugan, Janarthanan Venkatesan, Harashkumar Vasanthakumari Thirumalaiswamy,Charlene Gadais,Loganathan Rangasamy
ACS Infectious Diseases (2024)
Load More
Author Statistics
#Papers: 46
#Citation: 1321
H-Index: 18
G-Index: 33
Sociability: 5
Diversity: 2
Activity: 43
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn